BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31216203)

  • 1. Medullary Abnormalities in Appendicular Skeletons Detected With
    Abe Y; Narita K; Kobayashi H; Kitadate A; Takeuchi M; O'uchi T; Matsue K
    AJR Am J Roentgenol; 2019 Oct; 213(4):918-924. PubMed ID: 31216203
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment
    Abe Y; Narita K; Kobayashi H; Kitadate A; Miura D; Takeuchi M; O'uchi E; O'uchi T; Matsue K
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1325-1333. PubMed ID: 30687892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Baseline
    Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY
    Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of
    Han S; Woo S; Kim YI; Yoon DH; Ryu JS
    Eur Radiol; 2021 Jan; 31(1):152-162. PubMed ID: 32809165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of semi-quantitative parameters of
    Wan B; Zhang S; Wang P; Deng P; Dai W
    Ann Nucl Med; 2023 Mar; 37(3):155-165. PubMed ID: 36528697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of [
    Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Jung SH; Kwon SY; Min JJ; Bom HS; Ahn SY; Jung SY; Lee SS; Park MR; Yang DH; Ahn JS; Kim HJ; Lee JJ
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):107-115. PubMed ID: 30187105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Evaluation of Magnetic Resonance Imaging and [
    Moreau P; Attal M; Caillot D; Macro M; Karlin L; Garderet L; Facon T; Benboubker L; Escoffre-Barbe M; Stoppa AM; Laribi K; Hulin C; Perrot A; Marit G; Eveillard JR; Caillon F; Bodet-Milin C; Pegourie B; Dorvaux V; Chaleteix C; Anderson K; Richardson P; Munshi NC; Avet-Loiseau H; Gaultier A; Nguyen JM; Dupas B; Frampas E; Kraeber-Bodere F
    J Clin Oncol; 2017 Sep; 35(25):2911-2918. PubMed ID: 28686535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
    Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low hexokinase-2 expression-associated false-negative
    Abe Y; Ikeda S; Kitadate A; Narita K; Kobayashi H; Miura D; Takeuchi M; O'uchi E; O'uchi T; Matsue K
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1345-1350. PubMed ID: 30903198
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Morales-Lozano MI; Rodriguez-Otero P; Sancho L; Nuñez-Cordoba JM; Prieto E; Marcos-Jubilar M; Rosales JJ; Alfonso A; Guillen EF; San-Miguel J; Garcia-Velloso MJ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
    Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of an
    Dong X; Wang R; Ying X; Xu J; Yan J; Xu P; Peng Y; Chen B
    Hematology; 2024 Dec; 29(1):2329029. PubMed ID: 38488443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.
    Zamagni E; Patriarca F; Nanni C; Zannetti B; Englaro E; Pezzi A; Tacchetti P; Buttignol S; Perrone G; Brioli A; Pantani L; Terragna C; Carobolante F; Baccarani M; Fanin R; Fanti S; Cavo M
    Blood; 2011 Dec; 118(23):5989-95. PubMed ID: 21900189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients.
    Zhong X; Diao W; Zhao C; Jia Z
    Nucl Med Commun; 2020 Sep; 41(9):950-958. PubMed ID: 32796484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of
    Tu H; He Y; Huang T; Choe S; Lan X; Duan X; Sattar H; Li C; Zhou F
    Eur J Haematol; 2018 Feb; 100(2):189-197. PubMed ID: 29226428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients].
    Wang CY; Wu L; Sun CT; Wang X; Xia B; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(4):301-306. PubMed ID: 30669718
    [No Abstract]   [Full Text] [Related]  

  • 18. [
    Chen Z; Yang A; Chen A; Dong J; Lin J; Huang C; Zhang J; Liu H; Zeng Z; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1926-1936. PubMed ID: 38286937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility and prognostic value of
    Aljama MA; Sidiqi MH; Buadi FK; Lacy MQ; Gertz MA; Dispenzieri A; Dingli D; Muchtar E; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Warsame RM; Kourelis T; Hwa YL; Kapoor P; Kyle RA; Leung N; Go RS; Rajkumar SV; Kumar SK
    Am J Hematol; 2018 Dec; 93(12):1518-1523. PubMed ID: 30194770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.